Tuesday, May 21, 2019

Inhibrx Finds $40M For Protein Engineering Tools

San Diego-based Inhibrx, a biopharmaceuticals startup working in the area of protein engineering, has raised $40M in an investment from Viking Global Investors, the company announced this mroning. Inhibrx said it has now raised approximately $205M in total, including $135M in equity and debt and $70M in licensing and grants. Inibrx has previously raised

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.

---